Anti-Wrinkle Treatment in India
Get Anti-Wrinkle Treatment at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Anti-Wrinkle Treatment in UAE
Anti-Wrinkle Treatment at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Anti-wrinkle treatments — encompassing botulinum toxin type A injections (Botox, Dysport, Xeomin), dermal fillers, and advanced energy-based skin resurfacing — are among the most precisely calibrated aesthetic medicine procedures available today, delivering measurable reduction in dynamic and static facial lines with patient satisfaction rates consistently exceeding 90% in peer-reviewed literature. International patients choose India and the UAE for these treatments through GAF Healthcare because they gain access to board-certified plastic surgeons and dermatologists trained at globally accredited institutions, state-of-the-art aesthetic clinics holding JCI, NABH, and DHA accreditations, and a significant cost advantage compared to Western markets — all with concierge-level support from arrival to departure.
Hospital Stay: 0 days (outpatient procedure; no hospital admission required in the vast majority of cases) • Total Stay in Country (Fit-to-Fly): 1–3 days (for injectable treatments); 7–14 days (for ablative laser or surgical adjuncts such as brow lift or blepharoplasty) • Success Rate: 91–96% patient satisfaction rate across combined injectable and energy-based modalities (based on multi-centre aesthetic medicine outcome data)
What Is It?
Facial wrinkling is a multifactorial process driven by the cumulative degradation of dermal collagen and elastin fibers (estimated 1% annual collagen loss after age 25), repetitive neuromuscular activity of facial expression muscles, photoageing from ultraviolet-induced oxidative stress, and progressive volume deflation of subcutaneous fat compartments. Histologically, intrinsic ageing causes a reduction in fibroblast density and glycosaminoglycan content, leading to impaired dermal hydration and structural support. Dynamic wrinkles — glabellar lines, forehead furrows, lateral canthal lines (crow's feet), and perioral lines — result primarily from hyperactive mimetic musculature and respond optimally to neuromodulator therapy. Static wrinkles, which persist at rest, involve deeper structural changes and typically require combined approaches including volumisation with hyaluronic acid or calcium hydroxylapatite fillers, and skin surface remodelling.
The modern standard of care in anti-wrinkle medicine is a personalised, anatomically informed treatment plan that integrates validated photographic assessment tools (Global Aesthetic Improvement Scale, Wrinkle Severity Rating Scale), three-dimensional facial analysis, and an understanding of facial fat compartment anatomy and the retaining ligament system. Leading aesthetic practitioners today stratify patients using Glogau's Photoageing Classification (Type I–IV) to select the optimal modality or combination. Type I–II patients (mild to moderate dynamic lines) are managed with neuromodulators alone; Type II–III patients benefit from combination neuromodulator and filler therapy; Type III–IV patients with significant static wrinkling, skin laxity, and textural changes may additionally require radiofrequency microneedling (e.g., Morpheus8, Thermage), fractional CO₂ or Er:YAG laser resurfacing, high-intensity focused ultrasound (HIFU/Ultherapy), or surgical correction.
The standard of care at JCI- and NABH-accredited facilities in India, and JCI- and DHA-licensed clinics in Dubai and Abu Dhabi, mandates pre-treatment medical history screening (including allergy profiling, bleeding disorder assessment, and pregnancy/lactation status), adherence to internationally validated dosing protocols for botulinum toxin products, the use of FDA/CE-marked devices and injectables only, and structured follow-up at two weeks for neuromodulator touch-up evaluation. Aseptic injection technique, appropriate needle gauge selection (30–32G), and anatomical knowledge of danger zones — particularly the supratrochlear and supraorbital arteries, the facial artery, and the infraorbital foramen — are non-negotiable clinical competencies at GAF Healthcare's partner institutions.
Candidates
• IDEAL CANDIDATES FOR NEUROMODULATOR (BOTULINUM TOXIN) THERAPY:
• Adults aged 25–70 with dynamic facial lines (Glogau Type I–III) causing aesthetic concern
• Patients with active glabellar complex hyperactivity, frontalis overaction, periorbital orbicularis oculi rhytids, or masseter hypertrophy (for facial slimming)
• Individuals in good general health with realistic expectations about temporary (3–6 month) outcomes
• Patients seeking preventive anti-ageing intervention before lines become static
• IDEAL CANDIDATES FOR DERMAL FILLER THERAPY:
• Adults with static nasolabial folds, marionette lines, perioral rhytids, or mid-face volume loss
• Patients with lip volume deficiency or lip line definition loss
• Individuals with hollow tear troughs or temporal wasting (Glogau Type II–III)
• IDEAL CANDIDATES FOR ENERGY-BASED DEVICES (HIFU, RF MICRONEEDLING, FRACTIONAL LASER):
• Patients with mild to moderate skin laxity who are not surgical candidates or prefer non-surgical options
• Individuals with skin textural irregularities, enlarged pores, acne scarring combined with rhytids (Glogau Type II–IV)
• Patients with Fitzpatrick skin types I–IV for ablative lasers; Types I–VI for non-ablative HIFU and RF modalities
• REQUIRED PRE-TREATMENT ASSESSMENTS (NO IMAGING REQUIRED FOR STANDARD CASES; EXCEPTIONS NOTED):
• Comprehensive medical history and physical examination including facial anatomy assessment
• Standardised baseline photography (frontal, three-quarter, lateral views under standardised lighting)
• Allergy history — specifically prior reactions to botulinum toxin, lidocaine, hyaluronic acid, or collagen-based products
• Bleeding risk assessment (discontinue NSAIDs, vitamin E, fish oil, and blood thinners 7–10 days pre-procedure if medically safe)
• For surgical adjuncts (brow lift, blepharoplasty): full pre-anaesthetic blood panel, ECG if age >40 or cardiovascular risk factors present, ophthalmological assessment for blepharoplasty candidates
• ABSOLUTE CONTRAINDICATIONS:
• Known hypersensitivity to botulinum toxin or any excipient (human serum albumin, sodium chloride)
• Infection or active inflammation at the injection site
• Pregnancy and lactation (all injectables and energy-based devices)
• Neuromuscular junction disorders: myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis (ALS), motor neuropathies
• Concomitant aminoglycoside antibiotic therapy (potentiates neuromuscular blockade)
• RELATIVE CONTRAINDICATIONS:
• Active autoimmune conditions under immunosuppressive therapy (proceed with caution; specialist clearance required)
• Keloid or hypertrophic scar tendency (for laser/RF modalities)
• Unrealistic aesthetic expectations or body dysmorphic disorder (BDD) — mandatory psychological screening recommended
• Fitzpatrick skin types V–VI for ablative laser resurfacing (higher post-inflammatory hyperpigmentation risk; consider non-ablative alternatives)
Procedure
CATEGORY 1 — NEUROMODULATORS (BOTULINUM TOXIN TYPE A)
Botulinum toxin type A works by cleaving the SNARE protein complex (specifically SNAP-25) at the neuromuscular junction, thereby preventing acetylcholine vesicle fusion and blocking muscular contraction. The clinical result is a controlled, reversible chemodenervation lasting 3–6 months, after which axonal sprouting restores neuromuscular transmission.
Approved products available at GAF Healthcare partner clinics:
• Botox (onabotulinumtoxinA) — the FDA gold standard, with the most extensive evidence base
• Dysport (abobotulinumtoxinA) — faster onset (2–3 days vs. 5–7 days); diffuses over a slightly wider area; dose conversion ratio approximately 2.5:1 vs. Botox
• Xeomin (incobotulinumtoxinA) — complexing protein-free formulation; lower immunogenicity risk; preferred in patients with prior toxin resistance
• Nuceiva / Jeuveau (prabotulinumtoxinA) — newer-generation neuromodulator
Treatment areas and standard dosing ranges:
• Forehead lines: 10–20 units Botox equivalent
• Glabellar complex (procerus + corrugators): 20–30 units
• Lateral canthal lines (crow's feet): 12–24 units bilaterally
• Brow lift (chemical brow lift): 2–4 units per lateral brow
• Bunny lines (nasalis): 4–6 units
• Lip flip (orbicularis oris): 4–6 units
• Masseter reduction (bruxism / facial slimming): 40–60 units bilaterally
• Platysmal bands (Nefertiti lift): 20–40 units
• Hyperhidrosis (axillary): 50–100 units per axilla
CATE GORY 2 — DERMAL FILLERS
Dermal fillers restore lost volume, rehydrate the dermis, and provide structural scaffolding to effaced facial compartments. GAF Healthcare partner clinics use exclusively CE-marked and/or FDA-approved filler products.
Hyaluronic acid (HA) fillers — preferred first-line:
• Juvederm Ultra/Voluma/Volbella/Volux (Allergan): cross-linked BDDE HA; lidocaine-premixed; Volux provides high G-prime for jawline and chin structural support
• Restylane/Restylane Lyft/Defyne/Refyne (Galderma): XpresHAn Technology™ for dynamic zone adaptation
• Belotero Balance/Intense/Volume (Merz): cohesive polydensified matrix for superficial fine lines and tear troughs
Non-HA fillers (longer duration, non-reversible — used selectively):
• Radiesse (calcium hydroxylapatite): biostimulatory; induces de novo collagen synthesis; lasts 12–18 months; not reversible with hyaluronidase
• Sculptra (poly-L-lactic acid): volumising collagen biostimulator; requires 3 sessions; results develop over 3–6 months; lasts 18–24 months
Key procedural safety protocols: aspiration before injection in high-risk vascular zones, use of blunt cannulas in periocular and nasolabial regions, and availability of hyaluronidase on-site for emergency vascular occlusion reversal (minimum 1500 IU on hand).
CATEGORY 3 — ENERGY-BASED DEVICES
High-Intensity Focused Ultrasound (HIFU / Ultherapy):
Delivers precise thermal energy at depths of 1.5mm (dermis), 3mm (subdermis), and 4.5mm (SMAS layer), triggering neocollagenesis and myofibroblast contraction. FDA-cleared for brow lift, submental laxity, and décolletage lines. Single session; results appear over 3–6 months.
Radiofrequency Microneedling (Morpheus8, Thermage FLX, Genius RF):
Combines fractional microneedling (creating controlled microchannels at depths of 0.5–4mm) with bipolar or multipolar radiofrequency energy delivery directly into the deep reticular dermis and subdermis. Indicated for skin tightening, textural improvement, perioral and periorbital rhytids, and acne scarring. Suitable for all Fitzpatrick skin types when non-ablative settings are used.
Fractional CO₂ Laser Resurfacing (e.g., Lumenis UltraPulse, Fraxel Re:pair):
Ablative fractional photothermolysis creates microscopic zones of controlled thermal ablation, stimulating robust wound healing and collagen remodelling. Highly effective for Glogau Type III–IV static wrinkling. Requires 7–14 days social downtime. Fitzpatrick I–III preferred; Types IV–V managed with non-ablative alternatives.
Non-Ablative Fractional Laser (Fraxel Restore / 1550nm Er:Glass):
Preserves the epidermis; lower downtime (3–5 days); requires a series of 3–5 sessions for equivalent results to ablative.
Plasmage / Plasma Pen:
Non-laser, non-surgical device creating micro-arcs of plasma energy for eyelid tightening and periorbital rhytid reduction; an alternative to surgical blepharoplasty in mild cases.
SURGICAL ADJUNCTS (for Glogau Type III–IV patients or those not responding to non-surgical modalities):
• Endoscopic brow lift: addresses deep glabellar furrows and brow ptosis through 3–5 small scalp incisions with endoscopic visualisation; recovery 2–3 weeks
• Upper/lower blepharoplasty: surgical excision of redundant periorbital skin and herniated orbital fat; performed under local anaesthesia with sedation or general anaesthesia; recovery 7–14 days
• Thread lift (PDO/PLLA/PCL barbed threads): minimally invasive mechanical lift of mid-face and jowl tissue; combination with neuromodulators and fillers for comprehensive rejuvenation
Cost of Anti-Wrinkle Treatment: India vs. UAE
Anti-wrinkle treatments in India and the UAE offer international patients a compelling combination of clinical excellence and cost efficiency. The total investment varies significantly depending on the treatment modality chosen, the volume of product used, the number of anatomical zones treated, and the seniority and specialisation of the treating physician. As a general principle, comparable treatments performed at equally accredited institutions in India cost approximately 40–60% less than in the UAE, while UAE pricing itself represents a saving of 50–70% versus equivalent procedures in the United Kingdom, United States, or Western Europe. The figures below represent all-inclusive per-session estimates for standard combination anti-wrinkle treatment packages (neuromodulator + filler or energy-based device), as coordinated by GAF Healthcare.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $150 – $1,200 | ~53% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $350 – $2,500 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — PRE-TREATMENT (1–7 days before procedure)
• Day -7 to -3: Complete GAF Healthcare's online medical intake form; submit standardised facial photographs; teleconsultation with the treating specialist for treatment planning and product selection
• Day -7: Discontinue NSAIDs (ibuprofen, aspirin), vitamin E supplements, fish oil, and any anticoagulant medications (if medically safe to do so, with physician approval) to minimise bruising risk
• Day -3: Avoid alcohol consumption
• Day -1: Arrive at destination; confirm appointment; no specific fasting required for injectable procedures (general anaesthesia fasting protocols apply only for surgical adjuncts)
• Day 0 (Treatment Day Morning): Arrive at clinic 30 minutes early; medical history review; signed informed consent; baseline photography; topical anaesthetic cream (EMLA) applied 30–45 minutes prior for sensitive zones if requested
PHASE 2 — THE PROCEDURE (Day 0)
• Botulinum Toxin Injection: Duration 15–30 minutes. The reconstituted toxin (diluted in preserved normal saline at standard concentrations) is injected intramuscularly or intradermally using 30–32G needles at pre-mapped injection points. Immediate mild erythema and punctate bruising are normal. The patient remains seated during the procedure.
• Dermal Filler Injection: Duration 30–60 minutes depending on treatment zones. Blunt cannula technique used in periocular and nasolabial zones; fine-gauge needles (27–30G) for superficial lip work. Immediate moulding performed post-injection; light massage applied to ensure uniform distribution.
• Energy-Based Device Sessions: HIFU session 60–90 minutes; RF microneedling 45–75 minutes with topical anaesthesia. Post-device care includes growth factor serum application and physical sunscreen.
• Surgical procedures (brow lift / blepharoplasty): Duration 1–3 hours under appropriate anaesthesia; brief recovery room observation before discharge (same-day for local/sedation cases)
PHASE 3 — IMMEDIATE POST-PROCEDURE (Day 0–3)
• Apply ice packs (indirect, wrapped in cloth) to treated areas for 15 minutes every hour for the first 4 hours
• Avoid strenuous exercise, alcohol, and heat exposure (saunas, hot showers) for 24–48 hours
• Sleep in elevated head position (30°) for 24 hours post-filler or post-surgical procedure
• Avoid facials, facial massage, and pressure on treated areas for 14 days post-filler
• Botulinum toxin: avoid lying down for 4 hours post-injection; avoid rubbing treated areas for 24 hours; do not exercise same day
PHASE 4 — EARLY RECOVERY & REVIEW (Day 3–14)
• Day 3–5: Most oedema and bruising resolves for injectable procedures; full effect of neuromodulators visible by Day 7–14
• Day 14: Follow-up appointment with treating physician for post-treatment photography, outcome assessment using GAIS (Global Aesthetic Improvement Scale), and botulinum toxin touch-up if required (standard clinical practice)
• Laser resurfacing patients: new epidermis forms by Day 7–10; sun avoidance mandatory for 4–6 weeks; SPF 50+ daily
• Surgical adjunct patients: suture removal typically Day 5–7; bruising resolves by Day 10–14
PHASE 5 — FIT-TO-FLY MILESTONES
• Neuromodulator and filler patients: fit to fly in 24–72 hours (Day 1–3) once acute swelling is manageable; ideally depart after Day 14 review
• Energy-based device (non-ablative HIFU/RF): fit to fly within 48–72 hours
• Ablative fractional CO₂ laser: fit to fly after skin re-epithelialisation, typically Day 7–10 minimum
• Surgical brow lift / blepharoplasty: fit to fly Day 10–14 post-surgery, after medical clearance by the surgeon
PHASE 6 — LONG-TERM MAINTENANCE
• Botulinum toxin effects last 3–6 months; maintenance sessions typically every 4 months
• HA filler longevity: 6–18 months depending on product rheology, treatment zone, and patient metabolism
• Biostimulators (Sculptra, Radiesse): 18–24 months
• Annual HIFU or RF microneedling sessions recommended for sustained collagen induction
• Daily broad-spectrum SPF 50+ sunscreen mandatory for photoprotection of results
Risks & Considerations
Anti-wrinkle injectable and energy-based treatments carry an excellent overall safety profile when performed by trained practitioners at accredited facilities; however, patients must be fully informed of the following specific risks:
Botulinum Toxin Risks: The most clinically significant adverse event is unintended spread of toxin to adjacent muscle groups — most consequentially, eyelid ptosis (incidence ~1–3%) from diffusion of glabellar toxin into the levator palpebrae superioris, or brow ptosis from over-weakening of the frontalis. Diplopia is a rare but serious complication of periocular injection. Dysphagia has been reported (rarely) with high-dose cervical or platysmal injections. Resistance or diminished response to neuromodulators may develop over time due to neutralising antibody formation, particularly with products containing complexing proteins; switching to Xeomin (protein-free) may restore responsiveness. Systemic spread causing generalised weakness is an extremely rare FDA black-box warning event. Minor expected effects include temporary bruising, local erythema, and mild headache.
Top Hospitals for Anti-Wrinkle Treatment
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
All India Institute of Medical Sciences (AIIMS)
New Delhi, India
Kokilaben Dhirubhai Ambani Hospital
Mumbai, India
Christian Medical College (CMC)
Vellore, India
Manipal Hospitals Dwarka
New Delhi, India
Top Doctors for Anti-Wrinkle Treatment
Internationally trained specialists in Cosmetic Surgery. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Anup Dhir
MBBS, MS, MCh (Plastic & Reconstructive Surgery), MD, FECSM
Plastic & Cosmetic Surgeon
Indraprastha Apollo Hospital, New Delhi, India
40+ Yearsof experience
Dr. Anup Dhir is a Senior Consultant in Plastic and Cosmetic Surgery with over 40 years of clinical experience. He holds a distinguished academic qualification including MBBS, MS, MCh in Plastic & Reconstructive Surgery, MD, and FECSM certification, reflecting his deep commitment to surgical excellence and international standards of care. Based at Indraprastha Apollo Hospital in New Delhi, Dr. Dhir has built a reputation for combining aesthetic refinement… Read more
Dr. Arvind Maharaj P M
MCh, MS, MBBS
Cosmetic & Plastic Surgeon
Gleneagles HealthCity Chennai, Chennai, India
10+ Yearsof experience
Dr. Arvind Maharaj P M is a Consultant in Cosmetic and Plastic Surgery with over 10 years of clinical experience. He completed his MCh in Plastic Surgery from Stanley Medical College, Tamil Nadu Dr. M.G.R. Medical University in 2013, following his MS in General Surgery from Netaji Subash Chandra Bose Medical College, Jabalpur in 2010, and his MBBS from Government Kilpauk Medical College in 2006. His rigorous academic training has provided him with a… Read more
Dr. Atul Sharma
MBBS, MS, DNB, MCh
Cosmetic & Plastic Surgeon
Fortis Memorial Research Institute, Gurgaon, India
17+ Yearsof experience
Dr. Atul Sharma is a Senior Consultant in Cosmetic and Plastic Surgery at Fortis Memorial Research Institute (FMRI) in Gurgaon, bringing over 17 years of specialized experience to complex aesthetic and reconstructive procedures. He holds an impressive educational foundation: MBBS, MS in General Surgery, DNB in Plastic Surgery, and MCh in Plastic Surgery from the prestigious Postgraduate Institute of Medical Education and Research (PGIMER). This… Read more
Dr. Bhumika Narang
MBBS, DNB, MCh, MNAMS
Cosmetic & Plastic Surgeon
Medanta — The Medicity, Gurugram, India
13+ Yearsof experience
Dr. Bhumika Narang is an Associate Consultant in Cosmetic and Plastic Surgery at Medanta — The Medicity in Gurugram, India. A gold medalist in her MBBS from UP University of Medical Sciences, she holds advanced qualifications including an MCh in Plastic and Reconstructive Surgery from SMS Medical College, Jaipur, and a DNB in General Surgery from the National Board of Examinations. With over 13 years of clinical experience, Dr. Narang brings surgical… Read more
Dr. Chandhana Vishal N
MBBS, MS (General Surgery), MCh (Plastic Surgery), Tamira Shiksha Aesthetic Fellowship, Interactive Aesthetic Fellowship
Cosmetic & Plastic Surgeon
Medicover Hospital, Bangalore, Bengaluru, India
10+ Yearsof experience
Dr. Chandhana Vishal N is a Consultant in Cosmetic, Reconstructive, and Aesthetic Surgery at Medicover Hospital in Bengaluru. With over 10 years of clinical experience, she has established herself as a trusted plastic surgery specialist across the southern region. She holds an MCh in Plastic Surgery along with specialized fellowships in aesthetic surgery, including the Tamira Shiksha Aesthetic Fellowship and Interactive Aesthetic Fellowship, complementing… Read more
Frequently Asked Questions — Anti-Wrinkle Treatment
The cost of anti-wrinkle treatment varies by modality and treatment zone. In India, at JCI- and NABH-accredited aesthetic clinics coordinated by GAF Healthcare, a comprehensive anti-wrinkle session — encompassing botulinum toxin injection for forehead, glabellar complex, and lateral canthal lines, and/or hyaluronic acid dermal filler for one or two zones — typically ranges from USD 150 to USD 1,200 per session. More extensive treatments combining multiple modalities (e.g., neuromodulator full face + Sculptra biostimulator + HIFU) at premium centres in Mumbai, Delhi, or Hyderabad may reach the higher end of this range. In the UAE (Dubai and Abu Dhabi), equivalent treatments at JCI- and DHA-licensed clinics range from USD 350 to USD 2,500 per session, reflecting higher operational costs, imported product pricing, and premium clinic environments. Both destinations represent substantial savings compared to equivalent treatments in the US (USD 400–5,000+), UK (GBP 300–3,500+), or Western Europe. All estimates through GAF Healthcare include the specialist consultation fee, the procedure itself, consumables (needles, cannulas, post-procedure topicals), and standard follow-up at Day 14. Product costs (units of botulinum toxin, volumes of filler) are itemised transparently before any commitment.
The required in-country stay before international air travel depends entirely on the modality of treatment received. For injectable treatments — botulinum toxin type A (Botox, Dysport, Xeomin) and hyaluronic acid or calcium hydroxylapatite dermal fillers — the minimum safe period before flying is typically 24–72 hours (1–3 days). During this time, the most acute swelling and any minor bruising can be assessed and managed. GAF Healthcare strongly recommends international patients plan to stay through the Day 14 follow-up appointment, as this allows for the physician to confirm optimal neuromodulator effect, perform any touch-up injection if required, and photograph final outcomes. For non-ablative energy-based treatments (HIFU, RF microneedling), fit-to-fly clearance is typically given within 48–72 hours. For ablative fractional CO₂ laser resurfacing, patients must wait for epidermal re-epithelialisation, which occurs over approximately 7–10 days, and should not fly with raw or crusting skin due to infection risk and cabin pressure effects on healing tissue. For surgical adjuncts such as endoscopic brow lift or blepharoplasty, the treating surgeon's medical clearance is required before flying, typically issued between Day 10 and Day 14 post-surgery. Prolonged cabin flights in an economy class seated position carry a documented risk of dependent oedema, and GAF Healthcare advises patients to arrange aisle seating and walk frequently during flights of more than 4 hours within the early post-treatment period.
Anti-wrinkle treatments consistently demonstrate among the highest patient satisfaction rates in all of aesthetic medicine. For botulinum toxin type A injections, published multi-centre clinical trials (including landmark studies in Dermatologic Surgery and the Journal of the American Academy of Dermatology) report patient satisfaction rates of 88–96%, with clinician-assessed improvement on the Wrinkle Severity Rating Scale (WSRS) reaching 'much improved' or 'very much improved' in over 90% of treated patients. Hyaluronic acid dermal fillers for nasolabial folds, marionette lines, and lip augmentation achieve GAIS (Global Aesthetic Improvement Scale) ratings of 'improved' to 'much improved' in 89–95% of subjects. High-Intensity Focused Ultrasound (HIFU/Ultherapy) demonstrates clinician-assessed brow lift and submental improvement in approximately 79–87% of patients at six months, with collagen induction effects continuing for up to 12 months. Fractional CO₂ laser resurfacing for periorbital and perioral rhytids yields measurable wrinkle depth reduction in 85–93% of patients at 3-month assessment. It is essential to understand that 'success' in anti-wrinkle medicine is defined as meaningful, clinically verified aesthetic improvement — not the elimination of all lines. No injectable or energy-based treatment produces the degree of correction achieved by surgical facelift, and individual results vary based on skin type, anatomical characteristics, lifestyle factors (smoking, sun exposure, hydration), and the expertise of the treating practitioner. GAF Healthcare partner clinics establish transparent outcome benchmarks and realistic expectations during the pre-treatment teleconsultation, using validated photographic assessment tools and published clinical evidence to guide goal-setting.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides end-to-end non-medical support to ensure that international patients can focus entirely on their treatment and recovery without logistical anxiety.
VISA ASSISTANCE — INDIA: GAF Healthcare facilitates the e-Medical Visa (e-MV) application for India, which allows international patients and up to two attendants to enter India for medical treatment purposes. The e-Medical Visa is typically processed within 72 hours of application. GAF Healthcare's patient coordination team provides the official medical invitation letter from the treating hospital — a mandatory document for the e-MV application — and guides patients through the Ministry of Health and Family Welfare online portal. The e-Medical Visa permits a stay of up to 60 days and is extendable in-country.
VISA ASSISTANCE — UAE (DUBAI / ABU DHABI): Citizens of over 50 countries (including the EU, UK, US, Canada, Australia, GCC nations, and many Asian nations) receive visa-on-arrival or visa-free access to the UAE for stays of 30–90 days. For nationalities requiring a prior visa, GAF Healthcare coordinates the UAE medical treatment visa or standard tourist visa application. The UAE requires no special medical visa category for outpatient aesthetic procedures, simplifying the entry process significantly.
AIRPORT TRANSFERS: GAF Healthcare arranges private, air-conditioned vehicle pickup from the international terminal at all major Indian airports (Delhi IGI, Mumbai Chhatrapati Shivaji, Chennai, Hyderabad, Bangalore) and UAE airports (Dubai International DXB, Dubai World Central DWC, Abu Dhabi AUH), with a professional driver and patient coordinator assigned. Post-procedure, the same transfer service ensures safe, comfortable return transport without the patient needing to navigate public transport.
DEDICATED PATIENT COORDINATORS & TRANSLATORS: Every patient is assigned a dedicated multilingual case manager who speaks the patient's preferred language (available languages include English, Arabic, Russian, French, Swahili, Bahasa Indonesia, and others on request). This coordinator manages all scheduling, hospital documentation, prescription handling, and communication between the patient and the medical team throughout the stay.
ACCOMMODATION: GAF Healthcare has negotiated rates at partner hotels and serviced apartments ranging from 3-star to 5-star, all within 5–15 minutes of the treating hospital. For patients undergoing longer recovery stays (e.g., post-laser or post-surgical), options include hospital-adjacent recovery suites with daily nursing check-ins. Accommodation for one accompanying attendant is included in all standard GAF Healthcare treatment packages. Halal meal arrangements, international cuisine preferences, and accessibility requirements can be pre-arranged upon request.
TELEMEDICINE FOLLOW-UP: Post-return, GAF Healthcare facilitates structured teleconsultation sessions with the treating physician at Day 14 and Month 3, ensuring continuity of care and professional assessment of treatment outcomes from the patient's home country.
Patients Also Explore
Other treatments commonly sought by patients considering Anti-Wrinkle Treatment.
LASIK Eye Surgery
Ophthalmology
Cataract Surgery
Ophthalmology
Cochlear Implant
ENT
Hyperthyroidism Treatment
ENT